VPIM
Vanguard Personalized Indexing Management Portfolio holdings
AUM
$8.86B
This Quarter Return
+4.71%
1 Year Return
+26.43%
3 Year Return
+118.27%
5 Year Return
+211.61%
10 Year Return
–
AUM
$6.62B
AUM Growth
+$6.62B
(+6.6%)
Cap. Flow
+$353M
Cap. Flow
% of AUM
5.33%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
1,907
New
132
Increased
1,128
Reduced
530
Closed
101
Top Buys
| 1 |
Apple
AAPL
|
$19.7M |
| 2 |
NVIDIA
NVDA
|
$19.7M |
| 3 |
Microsoft
MSFT
|
$17.9M |
| 4 |
Amazon
AMZN
|
$17.5M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$12.9M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$4.91M |
| 2 |
MRO
Marathon Oil Corporation
MRO
|
$4.52M |
| 3 |
PepsiCo
PEP
|
$3.25M |
| 4 |
AGR
Avangrid, Inc.
AGR
|
$2.45M |
| 5 |
Adobe
ADBE
|
$2.31M |
Sector Composition
| 1 | Technology | 32.07% |
| 2 | Financials | 13.78% |
| 3 | Consumer Discretionary | 11.16% |
| 4 | Healthcare | 9.78% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
RLX Technology
RLX
$3.09B
| $47.9K | ﹤0.01% |
22,191
+7,052
| +47% | +$15.2K |
|
1702
RAPT Therapeutics
RAPT
$188M
| $46.9K | ﹤0.01% |
+29,657
| New | +$46.9K |
|
1703
EVgo
EVGO
$521M
| $46.3K | ﹤0.01% |
11,427
+67
| +0.6% | +$271 |
|
1704
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $45.9K | ﹤0.01% |
+33,228
| New | +$45.9K |
|
|
RVNC
1705
DELISTED
Revance Therapeutics, Inc.
RVNC
| $45.8K | ﹤0.01% |
15,056
+712
| +5% | +$2.16K |
|
1706
Hyliion Holdings
HYLN
$295M
| $45.2K | ﹤0.01% |
17,319
+1,566
| +10% | +$4.09K |
|
1707
Olaplex Holdings
OLPX
$954M
| $44.7K | ﹤0.01% |
25,820
-1,643
| -6% | -$2.84K |
|
1708
Allogene Therapeutics
ALLO
$251M
| $43.7K | ﹤0.01% |
20,513
+4,716
| +30% | +$10K |
|
1709
Information Services Group
III
$249M
| $43.5K | ﹤0.01% |
13,019
-103
| -0.8% | -$344 |
|
1710
Sabre
SABR
$706M
| $43.2K | ﹤0.01% |
11,835
+234
| +2% | +$854 |
|
1711
ImmunityBio
IBRX
$2.21B
| $42.9K | ﹤0.01% |
16,742
+2,806
| +20% | +$7.18K |
|
|
ALLK
1712
DELISTED
Allakos
ALLK
| $42.4K | ﹤0.01% |
35,026
+9,105
| +35% | +$11K |
|
|
OPI
1713
Office Properties Income Trust
OPI
$15.8M
| $42K | ﹤0.01% |
42,017
+15,296
| +57% | +$15.3K |
|
1714
Cabaletta Bio
CABA
$133M
| $41.8K | ﹤0.01% |
18,413
+8,240
| +81% | +$18.7K |
|
1715
Metagenomi
MGX
$65.3M
| $41.8K | ﹤0.01% |
+11,577
| New | +$41.8K |
|
1716
GrafTech
EAF
$255M
| $39.7K | ﹤0.01% |
22,972
+6,734
| +41% | +$11.7K |
|
|
AGEN
1717
Agenus
AGEN
$133M
| $39.7K | ﹤0.01% |
+14,472
| New | +$39.7K |
|
|
GPMT
1718
Granite Point Mortgage Trust
GPMT
$137M
| $39.5K | ﹤0.01% |
14,170
-1,328
| -9% | -$3.71K |
|
|
ME
1719
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $39.5K | ﹤0.01% |
12,161
-24,800
| -67% | -$80.6K |
|
1720
Inovio Pharmaceuticals
INO
$126M
| $38.6K | ﹤0.01% |
+21,112
| New | +$38.6K |
|
|
LAC
1721
Lithium Americas
LAC
$723M
| $38.6K | ﹤0.01% |
12,996
+2,724
| +27% | +$8.09K |
|
1722
Nine Energy Service
NINE
$29.8M
| $38.3K | ﹤0.01% |
34,216
-6,737
| -16% | -$7.55K |
|
1723
CytomX Therapeutics
CTMX
$336M
| $38.1K | ﹤0.01% |
+36,992
| New | +$38.1K |
|
1724
Amprius Technologies
AMPX
$887M
| $37.6K | ﹤0.01% |
+13,439
| New | +$37.6K |
|
1725
Ventyx Biosciences
VTYX
$171M
| $37.1K | ﹤0.01% |
+16,944
| New | +$37.1K |
|